Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Cash Flow-to-Debt Ratio
Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥399.43 Million could theoretically repay 0% of its total liabilities (CN¥4.70 Billion) in one year. See free cash flow generation of Shenzhen Hepalink Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Shenzhen Hepalink Pharmaceutical Co Ltd across 20 annual periods. Also explore 002399 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
Year-by-year debt coverage analysis for Shenzhen Hepalink Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Shenzhen Hepalink Pharmaceutical Co Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | CN¥1.71 Billion | CN¥4.55 Billion | ▼ -11.8% |
| 2024 | 0.43x | CN¥2.19 Billion | CN¥5.14 Billion | ▲ +673.2% |
| 2023 | 0.06x | CN¥398.22 Million | CN¥7.22 Billion | ▲ +161.3% |
| 2022 | -0.09x | CN¥-756.61 Million | CN¥8.41 Billion | ▼ -10197.5% |
| 2021 | 0.00x | CN¥-6.63 Million | CN¥7.58 Billion | ▼ -117.2% |
| 2020 | 0.01x | CN¥37.28 Million | CN¥7.34 Billion | ▲ +117.4% |
| 2019 | -0.03x | CN¥-227.60 Million | CN¥7.77 Billion | ▼ -132.5% |
| 2018 | 0.09x | CN¥667.87 Million | CN¥7.41 Billion | ▲ +221.8% |
| 2017 | -0.07x | CN¥-407.12 Million | CN¥5.50 Billion | ▼ -203.2% |
| 2016 | 0.07x | CN¥346.07 Million | CN¥4.83 Billion | ▼ -72.9% |
| 2015 | 0.26x | CN¥893.71 Million | CN¥3.38 Billion | ▼ -54.2% |
| 2014 | 0.58x | CN¥912.80 Million | CN¥1.58 Billion | ▼ -72.0% |
| 2013 | 2.07x | CN¥420.97 Million | CN¥203.80 Million | ▼ -6.5% |
| 2012 | 2.21x | CN¥473.89 Million | CN¥214.53 Million | ▼ -90.6% |
| 2011 | 23.43x | CN¥1.41 Billion | CN¥59.98 Million | ▲ +582.9% |
| 2010 | 3.43x | CN¥354.86 Million | CN¥103.44 Million | ▲ +195.4% |
| 2009 | 1.16x | CN¥355.81 Million | CN¥306.33 Million | ▲ +684.7% |
| 2008 | 0.15x | CN¥40.13 Million | CN¥271.09 Million | ▲ +19.0% |
| 2007 | 0.12x | CN¥13.85 Million | CN¥111.28 Million | ▼ -55.3% |
| 2006 | 0.28x | CN¥71.66 Million | CN¥257.68 Million | — |